LeanLife Appoints Operations Advisor
February 06 2019 - 8:00AM
LeanLife Health Inc. (CSE: LLP) (the “Company”) announces that the
Company has hired an Operations Advisor.
The Company introduces Mr. Chris Nichols as an
on-call advisor to Operations Manager, Glenn Nichols, in the design
and validation of LeanLife’s full scale production process.
Chris Nichols has over 25 years of senior
operations leadership experience in all aspects of food-based fast
moving consumer goods (FMCG) manufacturing with several large
multi-national companies such as COCA-COLA,
MOLSON COORS and LANTIC (ROGERS)
SUGAR.
Holding a B.Sc. from Simon Fraser University
combined with technical work experience in processing line design,
optimization and operation, including aseptic processing, makes him
a great resource in the development of our facility.
Chris also has a strong background in HACCP and
GMP food safety systems and experience in building these
foundations into the process line’s physical and operational design
at early stages.
Using Lean Six Sigma tools and training, Chris
has implemented process improvement and optimization in every
position he has held leveraging that into multiple millions in
annualized cost savings in addition to managing dozens of capital
projects from design through to completion, on time and on budget,
while meeting all the project deliverables.
About LeanLife Health and the Omega-3
Market
LeanLife Health’s products are shelf-stable
extractions from flax seed, a plentiful and non-animal source of
Omega-3, that give them a significant advantage as a fortified food
ingredient.
The products can be used as food additives or as
nutraceuticals and have been used to make bread, noodles, cheese,
yogurt, juice and milk products for the European market.
LeanLife Health’s industry leading Omega-3
product formulations are of the highest quality and contain no
cholesterol. Products are available in oil, emulsion and powder
forms.
The global Omega-3 market reached $33 Billion
USD in 2016 and is expected to reach upwards of $57 Billion USD by
2025, according to a report by Grand View Research, Inc.
For more information, please contact:
Stan Lis, CEO604-764-0518SLis@LeanLifeHealth.com
Forward Looking InformationInformation set
forth in this news release contains forward-looking statements that
are based on assumptions as of the date of this news release. These
statements reflect management's current estimates, beliefs,
intentions and expectations. They are not guarantees of future
performance. The Company cautions that all forward looking
statements are inherently uncertain and that actual performance may
be affected by a number of material factors, many of which are
beyond the Company's control including, the Company's ability to
compete with large food companies; sales of any potential products
developed will be profitable; the ability to complete sales under
the sales agreement. Accordingly, actual and future events,
conditions and results may differ materially from the estimates,
beliefs, intentions and expectations expressed or implied in the
forward-looking information. Except as required under applicable
securities legislation, the Company undertakes no obligation to
publicly update or revise forward-looking information.
THE CSE HAS NEITHER APPROVED NOR
DISAPPROVED THE INFORMATION CONTAINED HEREIN AND DOES NOT ACCEPT
RESPONSIBILITY FOR THE ADEQUACY OR ACCURACY OF THIS
RELEASE.
LeanLife Health (CSE:LLP)
Historical Stock Chart
From Nov 2024 to Dec 2024
LeanLife Health (CSE:LLP)
Historical Stock Chart
From Dec 2023 to Dec 2024